Therapy Areas: Diabetes
Cirius Therapeutics introduces gestational diabetes initiative
29 April 2026 - Clinical-stage pharmaceutical company Cirius Therapeutics Incannounced on Tuesday a planning grant from the Gates Foundation to advance the development of CIR-0602K as a potential post...
Boehringer Ingelheim's survodutide phase 3 data show significant weight loss in obesity trial
28 April 2026 - Danish biotechnology company Zealand Pharma A/S (CPH:ZEAL) reported on Tuesday that pharmaceutical company Boehringer Ingelheim has achieved positive Phase 3 results for survodutide, a...
AOTI reports strong real-world outcomes for TWO2 wound therapy
27 April 2026 - Medical technology group AOTI INC (AIM: AOTI) on Monday announced results from a large real-world multicentre study demonstrating high rates of durable healing in chronic lower extremi...
Ascletis completes enrolment for US Phase II study of ASC30 in diabetes
27 April 2026 - Chinese pharmaceutical company Ascletis Pharma Inc (HKEX:1672) on Sunday announced completion of enrolment in its 13-week US Phase II study evaluating ASC30, an oral small molecule GLP...
Renalytix advances kidneyintelX.Dkd scale-up with laboratory expansion and CE submission
22 April 2026 - Precision medicine diagnostics company Renalytix plc (LSE: RENX) (OTCQB: RNLXY) revealed on Wednesday that it has completed key regulatory and operational milestones to support the sca...
FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children
22 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Wednesday that the US Food and Drug Administration (FDA) has approved an expanded indication for Tz...